...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: What if...?
Reply New Message
Back To Forum List View
What if...?
5
PVLee
Dec 12, 2015 09:41AM
Re: What if...?
1
PVLee
Dec 12, 2015 10:07AM
Re: What if...?

PVLee
Dec 12, 2015 11:20AM
Re: What if...?
4
fouremm
Dec 12, 2015 11:43AM

Fouremm,

I thought the RVX royalty preferred shares were set at the time of the spinout = 75+ million, no? Just the Zenith shares would get diluted, right?

1 Recommendations
Re: What if...?
5
fouremm
Dec 12, 2015 12:38PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply